These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 14524272)

  • 1. [Asthma with hypersensitivity to aspirin].
    Nizankowska-Mogilnicka E
    Pol Merkur Lekarski; 2003 Jun; 14(84):561-5. PubMed ID: 14524272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broken balance in aspirin hypersensitivity.
    Szczeklik A; Sanak M
    Eur J Pharmacol; 2006 Mar; 533(1-3):145-55. PubMed ID: 16457808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences].
    de Weck A; Sanz ML; Gamboa P
    Bull Acad Natl Med; 2005 Jun; 189(6):1201-18; discussion 1218-20. PubMed ID: 16433444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthma and aspirin].
    Schiappoli M; Gani F; Frati F; Marcucci F; Senna G
    Recenti Prog Med; 2003 Feb; 94(2):79-87. PubMed ID: 12908375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin-sensitive asthma.
    Morwood K; Gillis D; Smith W; Kette F
    Intern Med J; 2005 Apr; 35(4):240-6. PubMed ID: 15836503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
    Schapowal AG; Simon HU; Schmitz-Schumann M
    Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
    Kowalski ML; Borowiec M; Kurowski M; Pawliczak R
    Allergy; 2007 Jun; 62(6):628-34. PubMed ID: 17508966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
    Fuentes-Beltrán A; Montes-Vizuet R; Valencia-Maqueda E; Negrete-García MC; García-Cruz Mde L; Teran LM
    Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma.
    Higashi A; Kumlin M; Higashi N; Daham K; Gaber F; Lindeberg A; James A; Skedinger M; Delin I; Gyllfors P; Dahlén SE; Dahlén B
    Int Arch Allergy Immunol; 2012; 158(3):299-306. PubMed ID: 22398682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.
    Kupczyk M; Kurmanowska Z; Kupryś-Lipińska I; Bocheńska-Marciniak M; Kuna P
    Respir Med; 2010 Oct; 104(10):1404-9. PubMed ID: 20452758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin-induced asthma as an important type of bronchial asthma].
    Sakakibara H; Suetsugu S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():106-15. PubMed ID: 8752493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
    Pfaar O; Klimek L
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
    Sanak M; Kiełbasa B; Bochenek G; Szczeklik A
    Clin Exp Allergy; 2004 Dec; 34(12):1899-904. PubMed ID: 15663565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesics and asthma.
    Szczeklik A; Nizankowska E; Mastalerz L; Szabo Z
    Am J Ther; 2002; 9(3):233-43. PubMed ID: 11941383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspirin and other nonsteroidal anti-inflammatory drugs hypersensitivity--mechanisms, diagnostics and treatment].
    Kupczyk M; Kuna P
    Pneumonol Alergol Pol; 2008; 76(5):366-77. PubMed ID: 19003768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.
    Nizankowska-Mogilnicka E; Bochenek G; Mastalerz L; Swierczyńska M; Picado C; Scadding G; Kowalski ML; Setkowicz M; Ring J; Brockow K; Bachert C; Wöhrl S; Dahlén B; Szczeklik A
    Allergy; 2007 Oct; 62(10):1111-8. PubMed ID: 17521312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do we know about the genetics of aspirin intolerance?
    Palikhe NS; Kim SH; Park HS
    J Clin Pharm Ther; 2008 Oct; 33(5):465-72. PubMed ID: 18834360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma.
    Micheletto C; Tognella S; Guerriero M; Dal Negro R
    Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):10-4. PubMed ID: 16544582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
    Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
    Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.